Psychedelics. Meditation. Nicotine. Endorphins. The smell of vanilla. Massage. Jazz.
Delightful Moments such as these are part of all human experience: the small, but powerful, separations from the daily humdrum when we feel stronger, calmer, more joyful, more in control, more distant from pain and anxiety.
Now, a range of new technologies has the potential to deliver these experiences. They range from transforming the human (genetics, neurosciences), to creating new forms of human chemistry (personal pharma), to changing human experience rather than the body (virtual and augmented reality).
By investing in these tech vectors of happiness, Joyance Partners is the first venture fund focused on health experience, not process.
As investors, we see great near-term investment opportunity in the transformation of the mind.
We believe that as new science emerges across bio, genetics, analytics, VR and AI, the individual experience of health will be transformed.
It's important to understand what you want to get out of your company, from quality of life to financial reward.
Join Joyance Partners and a panel of inspiring happiness experts for an exploration of how tech can impact the well-being of all individuals.
We believe creation tools pave the way for a 3D future, no matter how quickly or slowly it gets here.
We see an enormous investment opportunity in this emerging class of companies.